Study of Tepotinib Combined With Cetuximab in Participants With Left-Sided RAS/BRAF Wild Type Metastatic Colorectal Cancer (PERSPECTIVE)
Clinical trial NCT04515394 · TERMINATED
Trial details
- NCT number
- NCT04515394
- Sponsor
- EMD Serono Research & Development Institute, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-28
- Primary completion
- 2022-03-14
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.